Tag Archives: Ulcerative colitis
By Pharm Exec | Published: January 28, 2014
The gastrointestinal (GI) therapeutics market for Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD) in the Asia-Pacific (APAC) region will increase in value from $564m in 2012 to $784m by 2019 (a CAGR of 4.8%), according to a new report from GBI Research.
By admin | Published: May 13, 2009
Image via CrunchBase Three pharmaceutical companies recently took big steps into the world of social media, launching Facebook applications that give consumers the ability to download and interact with health information material. For those having a hard time keeping up with the rapidly evolving world of Web 2.0, a Facebook application (â€œappâ€ for short) is […]